Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2008
10/28/2008US7442546 Method of modulating inflammatory response
10/28/2008US7442545 Distinguising neural stem cells from neural progenitor cells
10/28/2008US7442544 Viral vector in which gene for Sendai viral protein selected from NP, P, and L proteins is deleted or inactivated while all other gene functions are retained; use as expression vector in e.g. gene therapy; efficient system for reconstituting Sendai virus
10/28/2008US7442536 proteins is "cysteinized" to permit easier conjugation to a targeting moiety
10/28/2008US7442535 Fusion protein incorporating a cysteinized ribonuclease
10/28/2008US7442534 Nucleic acids and polypeptides which resemble Rho and which interact with cell signalling pathways and proteins
10/28/2008US7442524 Conjugate comprising polypeptide with N-glycosylation site and sugar; increase blood clot formation for treatment of thrombocytopenia and hemophilia
10/28/2008US7442522 Nucleic acids encoding chromo or fluorescent proteins and method for using the same
10/28/2008US7442521 To generate transgenic, non-human plants or animals or site specific gene modifications in cell lines; fluorescent proteins high through-put screening assays; use as biosensors in prokaryotic and eukaryotic cells, fluorescence activated cell sorting applications, as markers following injection into cells
10/28/2008US7442519 KCNQ2-15 potassium channel
10/28/2008US7442397 PEGylated fibrinogen-based biomatrix
10/28/2008US7442390 Method for enhancing engraftment of cells using mesenchymal progenitor cells
10/28/2008US7442379 Recombinant Newcastle disease virus RNA expression systems and vaccines
10/28/2008US7442376 Glycoprotein hormone compositions containing two β subunits
10/28/2008CA2400585C Hydroperoxide lyase regulatory region
10/28/2008CA2263797C Methods for modulating seed mass by expression of a nucleic acid containing an ap2 domain
10/28/2008CA2074355C Method of producing fertile transgenic corn plants
10/27/2008CA2586748A1 Agents for prophylaxis or treatment of neurological diseases and conditions
10/24/2008CA2586194A1 High oil hybrid brassica line 46p50
10/23/2008WO2008128176A1 Influenza polynucleotides, expression constructs, compositions, and methods of use
10/23/2008WO2008128117A1 Methods for determining optimal techniques for vitrification of isolated cells
10/23/2008WO2008128069A1 Methods for diagnosing biological samples containing stem cells
10/23/2008WO2008127974A1 Stem cell-based culture system for drug development
10/23/2008WO2008127735A1 Il3ralpha antibody conjugates and uses thereof
10/23/2008WO2008127670A1 Autologous/allogeneic human dna grafting, anti-and reserve aging stem cell, and bone marrow compositions/methods
10/23/2008WO2008127655A1 Anti-alpha 6 beta 4 integrin antibodies and uses therof
10/23/2008WO2008127352A2 Knockout mice for pr01105, pro1279 or pro1783 coding genes
10/23/2008WO2008127271A2 Interleukin -13 binding proteins
10/23/2008WO2008127256A1 Control of cells and cell multipotentiality in three dimensional matrices
10/23/2008WO2008126952A1 Method for preparing a cell-erived extracellular matrix scaffold
10/23/2008WO2008126940A1 Novel t cell
10/23/2008WO2008126517A1 Novel slc17-type transporter protein in mammal and use thereof
10/23/2008WO2008126413A1 Tem8 peptides and vaccines comprising the same
10/23/2008WO2008126083A2 Methods for identification and selection of human embryonic stem cell derived cells
10/23/2008WO2008125119A1 Adaptive mutations allow establishment of jfh1-based cell culture systems for hepatitis c virus genotype 4a
10/23/2008WO2008125117A1 Cell culture system of a hepatitis c genotype 3a and 2a chimera
10/23/2008WO2008124933A1 Carbon and nitrogen-regulating gene and protein and modulation thereof
10/23/2008WO2008124872A1 Latent neural stem cell population
10/23/2008WO2008124863A1 Method of generating population of cells enriched for undifferentiated cells
10/23/2008WO2008109479A3 Methods for selecting cells with enhanced growth and production properties
10/23/2008WO2008105925A3 COMPOUNDS AND METHODS FOR MODULATING β-CATENIN/SMAD-7 INTERACTIONS
10/23/2008WO2008100936A3 Methods for isolating and using hematopoietic and embryonic stem cells of the peritoneal cavity
10/23/2008WO2008100555A3 Engineered lung tissue construction for high throughput toxicity screening and drug discovery
10/23/2008WO2008097926A3 Transient transfection with rna
10/23/2008WO2008073316A3 Identification and isolation of acute myeloid leukemia stem cells
10/23/2008WO2008070367A3 Mammalian cell-based immunoglobulin display libraries
10/23/2008WO2008063779A3 Cells expressing alpha-synuclein and uses therefor
10/23/2008WO2008063577A3 Phospholipase c zeta mediated oocyte activation
10/23/2008WO2008060705A3 Anti-dll4 antibodies and methods using same
10/23/2008WO2008055151A9 Templated islet cells and small islet cell clusters for diabetes treatment
10/23/2008WO2008053330A3 Monoclonal antibodies against the human anti-mullerian hormone type ii receptor (amhr-ii)
10/23/2008WO2008045919A3 Novel bone mineralization protein expression systems, and methods of studying their intracellular signaling pathways
10/23/2008WO2008025020A3 Cd30 binding agents and uses thereof
10/23/2008WO2008024996A3 Production of neural protective and regenerative factors from stem cells and treatment of nervous system conditions therewith
10/23/2008WO2008008814A3 Tissue transplantation compositions and methods
10/23/2008WO2008008550A3 Compositions and methods for growing human embryonic stem cells
10/23/2008WO2007146309A3 Methods for manipulating stem cells
10/23/2008WO2007136936A3 Dermis-derived cells for tissue engineering applications
10/23/2008WO2007131209A3 Pancreatic islet-like cells
10/23/2008WO2007130886A3 Nutritional supplement and use thereof
10/23/2008WO2007126787A3 Reagents and methods for cancer treatment and prevention
10/23/2008WO2007123765A3 Neutrokine-alpha and neutrokine-alpha splice variant
10/23/2008WO2007117565A3 Standardization of processes for culturing primary cells
10/23/2008WO2007109254A3 Stabilized polypeptide compositions
10/23/2008WO2007106707A3 Identification and engineering of antibodies with variant heavy chains and methods of using same
10/23/2008WO2007100870A3 Methods for compact aggregation of dermal cells
10/23/2008WO2007095746A9 Cancerous disease modifying antibodies
10/23/2008WO2007066779A9 Novel lipase
10/23/2008WO2007059190A3 Compositions of and methods of using stabilized psma dimers
10/23/2008WO2006135799A3 Detection of hookworm coproantigens
10/23/2008US20080263730 Nucleic acid molecules and other molecules associated with plants
10/23/2008US20080263729 Stress Tolerant Organisms Expressing a Map Kinase Homologue
10/23/2008US20080263728 Plastidial targeting peptide
10/23/2008US20080263727 Increased seed size and seed number through transgenic over expression of revoluta protein during early embryo development
10/23/2008US20080263725 expression of the nucleic acid sequence in the plant results in increased tolerance to environmental stress (drought, cold, oxidation)
10/23/2008US20080263724 Soybean cultivar 6265047
10/23/2008US20080263723 Alfalfa variety named magnum vi
10/23/2008US20080263722 Expression vector comprising nucleotide sequences coding dehydration response element binding factors(DREB1 and DREB2) for use as tools in generating drought and salt resistant crops
10/23/2008US20080263713 Transgenic seeds for propagation of disease, insect and herbicide resistant plants with enhanced fatty acid synthesis and carbohydrate metabolism; improving nutrient quality of crops
10/23/2008US20080263691 Expression vector comprising nuclelotide sequences coding troponin I (TnI) protein for use in treatment and prevention of congestive heart failure
10/23/2008US20080263689 Screening/monitoring rate of internalization of insulin receptors in insulin-stimulated hepatocytes; identifying modulators of insulin clearance and secretion; treating insulin resistance
10/23/2008US20080263687 Chimeric retinoid x receptors and their use in a novel ecdysone receptor-based inducible gene expression system
10/23/2008US20080263686 Animal model for pigment spots
10/23/2008US20080263685 Transgenic non-human animal expressing metabotropic glutamate receptor 1 in a melanocyte-specific manner for identifying modulators for prevention and treatment of cell proliferative disorders
10/23/2008US20080262102 Biodegradable polymer scaffolds for skeletal reconstruction; hydrogels with controllable hydrophilicity, swelling, mechanical properties; biocompatible, bioresorbable, injectable, and in-situ hardening; tissue engineering and controlled drug release; photocrosslinking; surgerical handling/positioning
10/23/2008US20080262093 Contacting a cell expressing PGC-1 with various amount of respiration uncoupling agent to determing the resulting maximum PGC-1 level and therefore the upper limit of the safe dosage for the agent; decreasing fat mass/adipocity or increasing weight loss; antidiabetic agents; eating/metabolic disorders
10/23/2008US20080262092 Regulation of osteopontin
10/23/2008US20080262087 Modified g-protein coupled receptor for identifying modulators of taste preception; artificial sweeteners
10/23/2008US20080262079 Cannabinoid Compositions and Methods of Use Thereof
10/23/2008US20080262016 Isoquinoline derivatives and methods of use thereof
10/23/2008US20080262003 Methods for treating neoplasia with combination of chemotherapeutic agents and radiation
10/23/2008US20080261966 Bis-aryl sulfonamides
10/23/2008US20080261956 Substituted Phenols as Active Agents Inhibiting Vegf Production
10/23/2008US20080261911 Uses of diphenyl/diphenylamine carboxylic acids
10/23/2008US20080261903 Isolated polynucleotide encoding a Regulated in chronic obstructive pulmonary disease Kinase polypeptide; host cell; hybridization; screening; prediction, diagnosis; prognosis; chronic obstructive pulmonary disease, asthma, cancer, diseases of defective cell signaling
10/23/2008US20080261888 Platelet-derived growth factor-D (PDGF-D); stimulating cell proliferation, angiogensis
10/23/2008US20080261883 Runx3 gene showing anti-tumor activity and use thereof
10/23/2008US20080261882 Methods for Inhibiting Heregulin and Treating Cancer
10/23/2008US20080261880 Synthetic approach to designed chemical structures
10/23/2008US20080261879 Activin (follistatin) receptors; inhibin; neuronal differentiation; transforming growth factors
1 ... 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 ... 1827